A 3369 New Jersey General Assembly · 2026-2027 Regular Session

Requires SHBP, SEHBP, Medicaid, and NJ FamilyCare to cover anti-obesity medications.

This bill requires New Jersey's State Health Benefits Program (SHBP), School Employees Health Benefits Program (SEHBP), Medicaid, and NJ FamilyCare to cover FDA-approved anti-obesity medications for eligible individuals. It mandates coverage when a patient has a diagnosed obesity or related condition, receives a prescription from a licensed provider (physician, PA, or nurse), and obtains the medication through an approved pharmacy. Medicaid and NJ FamilyCare coverage depends on securing federal approval for necessary program waivers. The law applies to all four programs for members meeting these medical criteria, aiming to expand access to weight management treatment.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2026
Committee Review
Floor Vote
Governor
Introduced Jan 13, 2026 Last action Jan 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 13, 2026
Introduced
Introduced, Referred to Assembly Health Committee
lower
1 primary · 2 co-sponsors

Sponsors